Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy J Opperman

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Antiviral Research|April 11, 2015
TAOK3 phosphorylates the methylenecyclopropane nucleoside MBX 2168 to its monophosphateGloria Komazin-Meredith, Steven C Cardinale, Katelyn Comeau, et al.
Mbio|July 20, 2017
Lack of AcrB Efflux Function Confers Loss of Virulence on <i>Salmonella enterica</i> Serovar TyphimuriumXuan Wang-Kan, Jessica M A Blair, Barbara Chirullo, et al.
The Journal of Antimicrobial Chemotherapy|October 14, 2023
Exposure of Escherichia coli to antibiotic-efflux pump inhibitor combinations in a pharmacokinetic model: impact on bacterial clearance and drug resistanceAlasdair P MacGowan, M L G Attwood, Alan R Noel, et al.
Antimicrobial Agents and Chemotherapy|November 20, 2013
Characterization of a novel pyranopyridine inhibitor of the AcrAB efflux pump of Escherichia coliTimothy J Opperman, Steven M Kwasny, Hong-Suk Kim, et al.
Antimicrobial Agents and Chemotherapy|July 15, 2015
Discovery of bacterial fatty acid synthase type II inhibitors using a novel cellular bioluminescent reporter assayJoselynn Wallace, Nicholas O Bowlin, Debra M Mills, et al.
Antimicrobial Agents and Chemotherapy|September 14, 2016
DNA Targeting as a Likely Mechanism Underlying the Antibacterial Activity of Synthetic Bis-Indole AntibioticsTimothy J Opperman, Steven M Kwasny, Jessica Bo Li, et al.
Bioorganic & Medicinal Chemistry|March 31, 2015
Structure-activity relationships of a novel pyranopyridine series of Gram-negative bacterial efflux pump inhibitorsSon T Nguyen, Steven M Kwasny, Xiaoyuan Ding, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 16, 2016
Molecular basis for inhibition of AcrB multidrug efflux pump by novel and powerful pyranopyridine derivativesHanno Sjuts, Attilio V Vargiu, Steven M Kwasny, et al.
Bioorganic & Medicinal Chemistry|November 19, 2013
Potent and broad-spectrum antibacterial activity of indole-based bisamidine antibiotics: synthesis and SAR of novel analogs of MBX 1066 and MBX 1090John D Williams, Son T Nguyen, Shen Gu, et al.
Plos One|October 25, 2016
Towards Development of Small Molecule Lipid II Inhibitors as Novel AntibioticsJamal Chauhan, Steven Cardinale, Lei Fang, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Antiviral Research|April 11, 2015
TAOK3 phosphorylates the methylenecyclopropane nucleoside MBX 2168 to its monophosphateGloria Komazin-Meredith, Steven C Cardinale, Katelyn Comeau, et al.
Mbio|July 20, 2017
Lack of AcrB Efflux Function Confers Loss of Virulence on <i>Salmonella enterica</i> Serovar TyphimuriumXuan Wang-Kan, Jessica M A Blair, Barbara Chirullo, et al.
The Journal of Antimicrobial Chemotherapy|October 14, 2023
Exposure of Escherichia coli to antibiotic-efflux pump inhibitor combinations in a pharmacokinetic model: impact on bacterial clearance and drug resistanceAlasdair P MacGowan, M L G Attwood, Alan R Noel, et al.
Antimicrobial Agents and Chemotherapy|November 20, 2013
Characterization of a novel pyranopyridine inhibitor of the AcrAB efflux pump of Escherichia coliTimothy J Opperman, Steven M Kwasny, Hong-Suk Kim, et al.
Antimicrobial Agents and Chemotherapy|July 15, 2015
Discovery of bacterial fatty acid synthase type II inhibitors using a novel cellular bioluminescent reporter assayJoselynn Wallace, Nicholas O Bowlin, Debra M Mills, et al.
Antimicrobial Agents and Chemotherapy|September 14, 2016
DNA Targeting as a Likely Mechanism Underlying the Antibacterial Activity of Synthetic Bis-Indole AntibioticsTimothy J Opperman, Steven M Kwasny, Jessica Bo Li, et al.
Bioorganic & Medicinal Chemistry|March 31, 2015
Structure-activity relationships of a novel pyranopyridine series of Gram-negative bacterial efflux pump inhibitorsSon T Nguyen, Steven M Kwasny, Xiaoyuan Ding, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 16, 2016
Molecular basis for inhibition of AcrB multidrug efflux pump by novel and powerful pyranopyridine derivativesHanno Sjuts, Attilio V Vargiu, Steven M Kwasny, et al.
Bioorganic & Medicinal Chemistry|November 19, 2013
Potent and broad-spectrum antibacterial activity of indole-based bisamidine antibiotics: synthesis and SAR of novel analogs of MBX 1066 and MBX 1090John D Williams, Son T Nguyen, Shen Gu, et al.
Plos One|October 25, 2016
Towards Development of Small Molecule Lipid II Inhibitors as Novel AntibioticsJamal Chauhan, Steven Cardinale, Lei Fang, et al.
Pageof 4